SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2176378

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2176378

Allergy Diagnostics and Therapeutics Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 277 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Description

Table of Contents

Introduction

Allergies affect hundreds of millions of people, ranging from seasonal hay fever and food reactions to severe, life-threatening anaphylaxis. The allergy diagnostics and therapeutics market covers the tests used to identify what a patient reacts to and the treatments used to control symptoms or change the underlying immune response, including antihistamines, corticosteroids, epinephrine, immunotherapy and biologics. In 2026, the market is valued at US$41.5 Bn and is projected to reach US$88.3 Bn by 2033, registering a CAGR of 11.40%. Growth reflects the steady rise of allergic disease linked to urbanisation, pollution, longer pollen seasons driven by climate change and increasing food allergy among children. Medical innovation is adding momentum, as new biologics and disease-modifying therapies offer patients more than short-term symptom relief. However, access remains uneven. Biologics and immunotherapy are costly and subject to payer restrictions, while many patients, especially outside high-income countries, remain undiagnosed or lack access to allergy specialists who can guide appropriate testing and long-term treatment.

Market Insights

The market is segmented by product, allergen type and therapy type. Products are divided into diagnostics, which identify sensitisation and guide treatment decisions, and therapeutics, which manage or modify allergic disease. Allergen types include inhaled allergens, food allergens, drug allergens, insect venom and others, reflecting the wide range of triggers patients encounter. Therapy types cover antihistamines, corticosteroids, epinephrine, immunotherapy and biologics, from everyday symptom control to emergency treatment and targeted immune modulation. Several trends are reshaping care. Molecular allergy diagnostics are gaining ground because they identify the specific proteins responsible for reactions, helping clinicians assess risk more precisely. Oral and sublingual immunotherapy are becoming more common as convenient alternatives to injections. Needle-free epinephrine options are emerging to make emergency treatment easier to carry and use, and biologics that target specific immune pathways are expanding treatment choices for severe disease. Vendors are responding by broadening approved indications, focusing on childhood food allergy and improving diagnostic accuracy and accessibility.

Drivers

The rising prevalence of allergic diseases is the leading driver, with high impact over the long term. Urbanisation, air pollution and climate change, which lengthens pollen seasons, are increasing the number of people affected by respiratory allergies, while food allergy among children is becoming more common in many countries. Each new patient requires diagnosis and, often, years of treatment, creating sustained demand across both testing and therapy. The second driver is the arrival of new biologics and disease-modifying therapies, a high-impact force over the medium term. These treatments target the underlying immune mechanisms of allergy rather than only relieving symptoms, offering better control for patients with severe or persistent conditions. Restraints remain important. The high cost of biologics and immunotherapy is a high-impact, long-term restraint, as payers impose restrictions and reimbursement limits that slow uptake. Underdiagnosis and limited access to specialists form a medium-impact restraint, particularly in Asia Pacific, Latin America and the Middle East and Africa, where many cases go unrecognised.

Business Opportunity

Food allergy therapies represent a significant opportunity. Food allergies can cause severe reactions and place a heavy burden on children and families, who must constantly avoid trigger foods. New oral and patch-based treatment options are being developed for young children, aiming to raise the threshold at which reactions occur and reduce the risk from accidental exposure. Treatments that can be started early in life and fit into family routines are likely to see strong demand from parents and paediatric specialists, opening a growing therapeutic segment. The second opportunity lies in molecular diagnostics and digital care. Component-resolved testing identifies the exact allergenic proteins involved, helping clinicians distinguish between mild and high-risk sensitisation and tailor treatment. Point-of-care tests bring faster results into primary care and clinics, while telemedicine extends specialist expertise to patients in areas with few allergists. Together, these tools can reduce underdiagnosis, improve treatment selection and connect more patients with appropriate therapies, expanding the overall market.

Region Analysis

North America leads the market with a 38.8% share in 2026. The region benefits from high awareness of allergic disease, strong access to specialists, broad availability of advanced diagnostics and relatively rapid adoption of biologics and new immunotherapy options. Asia Pacific is the fastest-growing region, expanding at a 13.6% CAGR through 2033, as urbanisation and pollution increase allergy rates and healthcare systems improve diagnosis and treatment, although underdiagnosis and limited specialist access remain challenges. Europe is a major market with a strong tradition of allergen immunotherapy, well-developed diagnostic services and growing use of biologics for severe conditions. Latin America shows rising demand as awareness grows and urban populations face more respiratory allergies, though specialist availability and reimbursement remain limited in many areas. The Middle East and Africa is developing gradually, with improving healthcare infrastructure and growing recognition of allergic disease, while gaps in diagnosis and access to specialists continue to restrain wider adoption of advanced testing and therapies.

Key Players

  • Sanofi
  • Regeneron Pharmaceuticals
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • ALK-Abello
  • Stallergenes Greer
  • HAL Allergy
  • bioMerieux
  • HYCOR Biomedical
  • Viatris

Segmentation

By Product:

  • Diagnostics
  • Therapeutics

By Allergen Type:

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Insect Venom
  • Others

By Therapy Type:

  • Antihistamines
  • Corticosteroids
  • Epinephrine
  • Immunotherapy
  • Biologics

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Allergy Diagnostics and Therapeutics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 3.1. Global Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Diagnostics
    • 3.1.2. Therapeutics
  • 3.2. Global Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Inhaled Allergens
    • 3.2.2. Food Allergens
    • 3.2.3. Drug Allergens
    • 3.2.4. Insect Venom
    • 3.2.5. Others
  • 3.3. Global Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 3.3.1. Antihistamines
    • 3.3.2. Corticosteroids
    • 3.3.3. Epinephrine
    • 3.3.4. Immunotherapy
    • 3.3.5. Biologics
  • 3.4. Global Allergy Diagnostics and Therapeutics Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 4.1. North America Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Diagnostics
    • 4.1.2. Therapeutics
  • 4.2. North America Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Inhaled Allergens
    • 4.2.2. Food Allergens
    • 4.2.3. Drug Allergens
    • 4.2.4. Insect Venom
    • 4.2.5. Others
  • 4.3. North America Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 4.3.1. Antihistamines
    • 4.3.2. Corticosteroids
    • 4.3.3. Epinephrine
    • 4.3.4. Immunotherapy
    • 4.3.5. Biologics
  • 4.4. North America Allergy Diagnostics and Therapeutics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 4.4.3. U.S. Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 4.4.4. Canada Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 4.4.6. Canada Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 5.1. Europe Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Diagnostics
    • 5.1.2. Therapeutics
  • 5.2. Europe Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Inhaled Allergens
    • 5.2.2. Food Allergens
    • 5.2.3. Drug Allergens
    • 5.2.4. Insect Venom
    • 5.2.5. Others
  • 5.3. Europe Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 5.3.1. Antihistamines
    • 5.3.2. Corticosteroids
    • 5.3.3. Epinephrine
    • 5.3.4. Immunotherapy
    • 5.3.5. Biologics
  • 5.4. Europe Allergy Diagnostics and Therapeutics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.3. Germany Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.4. Italy Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.6. Italy Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.7. France Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.8. France Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.9. France Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.10. U.K. Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.12. U.K. Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.13. Spain Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.15. Spain Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.16. Russia Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.18. Russia Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 5.4.19. Rest of Europe Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 5.4.21. Rest of Europe Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Diagnostics
    • 6.1.2. Therapeutics
  • 6.2. Asia Pacific Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Inhaled Allergens
    • 6.2.2. Food Allergens
    • 6.2.3. Drug Allergens
    • 6.2.4. Insect Venom
    • 6.2.5. Others
  • 6.3. Asia Pacific Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 6.3.1. Antihistamines
    • 6.3.2. Corticosteroids
    • 6.3.3. Epinephrine
    • 6.3.4. Immunotherapy
    • 6.3.5. Biologics
  • 6.4. Asia Pacific Allergy Diagnostics and Therapeutics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.2. China Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.3. China Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 6.4.4. Japan Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.6. Japan Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 6.4.7. South Korea Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.9. South Korea Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 6.4.10. India Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.11. India Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.12. India Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 6.4.13. Southeast Asia Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.15. Southeast Asia Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 6.4.16. Rest of SAO Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 6.4.18. Rest of SAO Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 7.1. Latin America Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Diagnostics
    • 7.1.2. Therapeutics
  • 7.2. Latin America Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Inhaled Allergens
    • 7.2.2. Food Allergens
    • 7.2.3. Drug Allergens
    • 7.2.4. Insect Venom
    • 7.2.5. Others
  • 7.3. Latin America Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 7.3.1. Antihistamines
    • 7.3.2. Corticosteroids
    • 7.3.3. Epinephrine
    • 7.3.4. Immunotherapy
    • 7.3.5. Biologics
  • 7.4. Latin America Allergy Diagnostics and Therapeutics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 7.4.3. Brazil Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 7.4.4. Mexico Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 7.4.6. Mexico Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 7.4.7. Argentina Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 7.4.9. Argentina Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 7.4.10. Rest of LATAM Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 7.4.12. Rest of LATAM Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Allergy Diagnostics and Therapeutics Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Allergy Diagnostics and Therapeutics Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Diagnostics
    • 8.1.2. Therapeutics
  • 8.2. Middle East & Africa Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Inhaled Allergens
    • 8.2.2. Food Allergens
    • 8.2.3. Drug Allergens
    • 8.2.4. Insect Venom
    • 8.2.5. Others
  • 8.3. Middle East & Africa Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, Value (US$ Bn), 2020-2033
    • 8.3.1. Antihistamines
    • 8.3.2. Corticosteroids
    • 8.3.3. Epinephrine
    • 8.3.4. Immunotherapy
    • 8.3.5. Biologics
  • 8.4. Middle East & Africa Allergy Diagnostics and Therapeutics Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 8.4.3. GCC Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 8.4.4. South Africa Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 8.4.6. South Africa Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 8.4.7. Egypt Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 8.4.9. Egypt Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 8.4.10. Nigeria Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 8.4.12. Nigeria Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
    • 8.4.13. Rest of Middle East Allergy Diagnostics and Therapeutics Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Allergy Diagnostics and Therapeutics Market Outlook, by Allergen Type, 2020-2033
    • 8.4.15. Rest of Middle East Allergy Diagnostics and Therapeutics Market Outlook, by Therapy Type, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Sanofi
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Regeneron Pharmaceuticals
    • 9.4.3. Thermo Fisher Scientific
    • 9.4.4. Siemens Healthineers
    • 9.4.5. ALK-Abello
    • 9.4.6. Stallergenes Greer
    • 9.4.7. HAL Allergy
    • 9.4.8. bioMerieux
    • 9.4.9. HYCOR Biomedical
    • 9.4.10. Viatris

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!